5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis
BackgroundSeveral studies have confirmed the impact of 5-aminolevulinic acid (5-ALA) on the extent of resection in newly diagnosed glioblastoma (GBM). However, there are controversies on the 5-ALA fluorescence status in recurrent GBM surgery, with specific reference to pseudoprogression or radionecr...
Main Authors: | Luca Ricciardi, Carmelo Lucio Sturiale, Alba Scerrati, Vito Stifano, Teresa Somma, Tamara Ius, Sokol Trungu, Michele Acqui, Antonino Raco, Massimo Miscusi, Giuseppe Maria Della Pepa |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fonc.2022.848036/full |
Títulos similares
-
The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma
por: Petrović Marko, et al.
Publicado: (2019-01-01) -
The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
por: Michael Baine, et al.
Publicado: (2021-01-01) -
The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosis
por: Arpita Sahu, et al.
Publicado: (2023-04-01) -
Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME)
por: Archya Dasgupta, et al.
Publicado: (2025-03-01) -
Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review
por: Ingrid Sidibe, et al.
Publicado: (2022-01-01)